|90 Day Gain
Aclaris Therapeutics rank is 242
Aclaris Therapeutics rank is 466
Aclaris Therapeutics has a low Put/Call ratio of 0.26 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Aclaris Therapeutics is ranked 760.
|Negative MACD Cross
The MACD Divergence has recently become negative while the MACD remains positive. This is typically a negative short-term indicator.
Aclaris Therapeutics has a high Put/Call ratio of 7.43 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Aclaris Therapeutics is ranked 105.
|Down EPS Surprise
Aclaris Therapeutics missed the consensus earnings estimate when it last reported quarterly earnings.
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Aclaris Therapeutics is ranked 857.